Cargando…
Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue
BACKGROUND: The human immunodeficiency virus type 1 (HIV-1) Vpu protein degrades CD4 and counteracts a restriction factor termed tetherin (CD317; Bst-2) to enhance virion release. It has been suggested that both functions can be genetically separated by mutation of a serine residue at position 52. H...
Autores principales: | Schindler, Michael, Rajan, Devi, Banning, Carina, Wimmer, Peter, Koppensteiner, Herwig, Iwanski, Alicja, Specht, Anke, Sauter, Daniel, Dobner, Thomas, Kirchhoff, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823648/ https://www.ncbi.nlm.nih.gov/pubmed/20078884 http://dx.doi.org/10.1186/1742-4690-7-1 |
Ejemplares similares
-
Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance
por: Kmiec, Dorota, et al.
Publicado: (2016) -
The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin
por: Kühl, Annika, et al.
Publicado: (2011) -
The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function
por: Kluge, Silvia F, et al.
Publicado: (2013) -
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
por: Sauter, Daniel, et al.
Publicado: (2011) -
In COS Cells Vpu Can Both Stabilize Tetherin Expression and Counteract Its Antiviral Activity
por: Waheed, Abdul A., et al.
Publicado: (2014)